Distribution and odds ratios (ORs) for the GP to suspect cancer according to the patient’s usual GP consultation frequencya
| GP-suspected cancer | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Observed | Crude | Adjustedb | |||||||
| Usual GP consultation frequencya | n | % | OR | (95% CI) | Trendc | OR | (95% CI) | Trendc | |
| Overall | |||||||||
| Rare (n = 748) | 361 | 48.3 | 1.09 | 0.92 to 1.30 | 1.14 | 0.95 to 1.37 | |||
| Average (n = 2219) | 1031 | 46.5 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 1018) | 434 | 42.6 | 0.83 | 0.71 to 0.96 | P= 0.018 | 0.78 | 0.66 to 0.91 | P<0.001 | |
| Females | |||||||||
| Rare (n = 303) | 158 | 52.1 | 1.02 | 0.79 to 1.32 | 1.03 | 0.77 to 1.39 | |||
| Average (n = 1036) | 536 | 51.7 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 534) | 245 | 45.9 | 0.77 | 0.63 to 0.96 | P= 0.059 | 0.72 | 0.57 to 0.91 | P= 0.032 | |
| Males | |||||||||
| Rare (n = 445) | 203 | 45.6 | 1.16 | 0.93 to 1.44 | 1.19 | 0.95 to 1.50 | |||
| Average (n = 1183) | 495 | 41.8 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 484) | 189 | 39.0 | 0.88 | 0.71 to 1.10 | P= 0.044 | 0.83 | 0.66 to 1.04 | P= 0.011 | |
| Age 18–44 years | |||||||||
| Rare (n = 63) | 26 | 41.3 | 0.80 | 0.44 to 1.45 | 0.86 | 0.46 to 1.62 | |||
| Average (n = 192) | 89 | 46.4 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 44) | 15 | 34.1 | 0.61 | 0.31 to 1.19 | P= 0.522 | 0.56 | 0.27 to 1.16 | P= 0.334 | |
| Age 45–54 years | |||||||||
| Rare (n = 121) | 56 | 46.3 | 0.81 | 0.52 to 1.25 | 0.90 | 0.55 to 1.46 | |||
| Average (n = 295) | 149 | 50.5 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 69) | 26 | 37.7 | 0.56 | 0.33 to 0.95 | P= 0.233 | 0.55 | 0.27 to 1.16 | P= 0.144 | |
| Age 55–64 years | |||||||||
| Rare (n = 227) | 102 | 44.9 | 1.12 | 0.82 to 1.53 | 1.20 | 0.87 to 1.65 | |||
| Average (n = 525) | 218 | 41.5 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 166) | 68 | 41.0 | 0.96 | 0.66 to 1.40 | P= 0.474 | 0.82 | 0.55 to 1.23 | P= 0.104 | |
| Age 65–74 years | |||||||||
| Rare (n = 229) | 116 | 50.7 | 1.34 | 0.98 to 1.82 | 1.39 | 1.00 to 1.93 | |||
| Average (n = 640) | 278 | 43.4 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 334) | 144 | 43.1 | 1.00 | 0.76 to 1.31 | P= 0.091 | 0.97 | 0.73 to 1.29 | P= 0.057 | |
| Age 75–84 years | |||||||||
| Rare (n = 87) | 50 | 57.5 | 1.33 | 0.82 to 2.16 | 1.39 | 0.83 to 2.34 | |||
| Average (n = 454) | 231 | 50.9 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 301) | 129 | 42.9 | 0.72 | 0.54 to 0.96 | P<0.05 | 0.69 | 0.50 to 0.94 | P<0.05 | |
| Age ≥85 years | |||||||||
| Rare (n = 21) | 11 | 52.4 | 0.78 | 0.31 to 1.96 | 0.49 | 0.18 to 1.32 | |||
| Average (n = 113) | 66 | 58.4 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 104) | 52 | 50.0 | 0.71 | 0.41 to 1.24 | P= 0.841 | 0.63 | 0.34 to 1.18 | P= 0.618 | |
| No comorbidity | |||||||||
| Rare (n = 665) | 318 | 47.8 | 1.07 | 0.89 to 1.28 | 1.15 | 0.95 to 1.40 | |||
| Average (n = 1803) | 830 | 46.0 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 654) | 283 | 43.3 | 0.89 | 0.74 to 1.07 | P= 0.101 | 0.79 | 0.65 to 0.96 | P<0.01 | |
| Moderate comorbidity | |||||||||
| Rare (n = 72) | 37 | 51.4 | 1.09 | 0.67 to 1.80 | 1.31 | 0.75 to 2.27 | |||
| Average (n = 361) | 173 | 47.9 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 292) | 123 | 42.1 | 0.79 | 0.58 to 1.08 | P= 0.213 | 0.80 | 0.58 to 1.11 | P= 0.093 | |
| High comorbidity | |||||||||
| Rare (n = 11) | 6 | 54.5 | 1.07 | 0.23 to 4.04 | 2.34 | 0.24 to 22.98 | |||
| Average (n = 55) | 28 | 50.9 | 1.00 | ref | 1.00 | ref | |||
| Frequent (n = 72) | 28 | 38.9 | 0.57 | 0.28 to 1.17 | P= 0.342 | 0.49 | 0.21 to 1.17 | P= 0.168 | |
↵a Usual consultation frequency defined according to the patient’s number of face-to-face contacts in the 19–36 months before the cancer diagnosis.
↵b Adjusted for sex, age group, diagnosis, comorbidity, disposable household income, and educational level. Estimates marked by bold were statistically significant at P≤0.05.
↵c Test for linear trend across categories. ref = reference